Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein

Biochem Biophys Res Commun. 1993 May 14;192(3):1175-81. doi: 10.1006/bbrc.1993.1540.

Abstract

Gelatinase B, a marker enzyme for chronic inflammatory diseases such as rheumatoid arthritis and multiple sclerosis (MS), was found to cleave human myelin basic protein (MBP). Human MBP was digested with gelatinase B from leukocytes. The MBP peptide fragments were separated by RP-HPLC and the gelatinase B cleavage sites established by aminoterminal sequence analysis. Several novel P1-P1' cleavage sites for gelatinase B were found. The positions of the cleavage sites in human MBP were such that at least one peptide coincided with a documented major MBP-autoantigen. This study annotates human MBP as a substrate for human gelatinase B, determines novel P1-P'1 cleavage sites and defines one of the metalloproteinases as a possible link in the pathogenesis of demyelinating diseases such as MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Biomarkers
  • Collagenases / blood*
  • Collagenases / isolation & purification
  • Electrophoresis, Polyacrylamide Gel
  • Humans
  • Matrix Metalloproteinase 9
  • Molecular Sequence Data
  • Myelin Basic Protein / metabolism*
  • Neutrophils / enzymology*
  • Peptide Fragments / isolation & purification
  • Substrate Specificity

Substances

  • Biomarkers
  • Myelin Basic Protein
  • Peptide Fragments
  • Collagenases
  • Matrix Metalloproteinase 9